Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00335114
Other study ID # F051025017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2005
Est. completion date April 2006

Study information

Verified date May 2023
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cyclosporine Ophthalmic Emulsion is currently used in the treatment of dry eye syndrome. Contact lens wearers frequently suffer from dry eye syndrome. The purpose of this study is to evaluate cyclosporine ophthalmic emulsion verses re-wetting drops in the relief of dry eye symptoms in contact lens wearers


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 2006
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - contact lens wearer - clinical diagnosis of dry eye syndrome Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
cyclosporine ophthalmic emulsion


Locations

Country Name City State
United States UAB Ophthalmology Services Foundation Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ocular exams and questionnaires at baseline and at 3 months will determine
Primary the effect of cyclosporine on dry eye syndrome.
Secondary Increased contact lens wearing time due to a decrease in severity
Secondary of dry eye symptoms